CONDITION
Cutaneous Lymphoma
Cutaneous lymphoma is a condition in which a type of immune cell called a lymphocyte becomes cancerous and accumulates in the skin. These cells normally circulate through the body as part of the immune system, but in cutaneous lymphoma they multiply abnormally and gather in patches, nodules, or more widespread areas of the skin. It can occur in dogs and cats, though the appearance and behaviour of the condition differ between species. Owners most often notice raised lumps, thickened patches of skin, reddened areas, ulceration, or changes in pigmentation that may appear in one location or several. The signs can sometimes resemble other skin conditions such as infection, allergy, or benign growths, which is why the condition is often investigated over time. In some cases, changes elsewhere in the body may develop later, but the skin is the primary site of concern at the outset. This page explores what signs may be observed, what is happening at a cellular level, how the condition is investigated through biopsy and staging, and what treatment approaches exist. The aim is to orient you to the shape of the condition and the decisions that may unfold over time.
Why this matters now
Cutaneous lymphoma tends to appear in middle-aged to older dogs, often between seven and eleven years, though younger animals can occasionally be affected. Certain breeds, including Cocker Spaniels, Boxers, and Scottish Terriers, appear more frequently in case series, though the condition occurs across many breeds and in mixed-breed dogs as well. In cats, the condition is less common overall and may appear at various ages, sometimes in association with prior viral exposure, though many cases arise without an identifiable trigger.
The condition may begin as a single small nodule or patch that persists despite treatment for presumed infection or allergy, or it may present with multiple lesions at the outset. Progression varies widely between individuals; some animals develop new areas of involvement over weeks to months, whilst others remain relatively stable for extended periods. The skin may remain the only site of disease throughout, or internal involvement may develop later, a pattern that cannot be predicted reliably at the time of diagnosis.
Signals & patterns
Early signals
Raised nodules or plaques
Firm, raised areas may appear on the trunk, head, or limbs, sometimes feeling slightly thickened beneath the skin. They may be skin-coloured, reddened, or darker, and can be mistaken for cysts or benign growths.
Persistent reddened patches
Areas of redness that do not resolve with treatment for infection or allergy may remain for weeks or gradually expand. The skin in these areas may feel slightly thicker than surrounding tissue.
Scaling or flaking
The surface of affected areas may become scaly, with fine or coarse flakes, sometimes resembling dry skin or seborrhoea. This pattern can persist despite topical treatment.
Localised hair loss
Hair may thin or fall out over nodules or patches, leaving smooth or mildly textured skin beneath. The loss tends to occur gradually rather than suddenly.
Later signals
Ulceration or crusting
Lesions may break down, forming open sores that weep or crust over. These areas can become secondarily infected, adding odour or discharge to the clinical picture.
Widespread skin thickening
The skin may become diffusely thickened, sometimes with a leathery texture, affecting large areas of the body. This change can alter the animal's appearance and may be accompanied by itching or discomfort.
Mucosal involvement
The gums, lips, or nasal passages may develop nodules or colour changes, appearing swollen or ulcerated. This pattern can affect eating or breathing in some cases.
Generalised changes
Weight loss, reduced appetite, or lethargy may emerge over time, particularly if the disease extends beyond the skin. These signs are not specific but reflect a broader shift in the animal's condition.
Click to read about the biological mechanisms
How this is usually investigated
Investigation typically begins with a detailed history of how the skin changes appeared and evolved, alongside a careful physical examination to map the distribution and character of lesions. Because cutaneous lymphoma can resemble many other skin conditions, diagnosis often requires tissue sampling. The extent of further testing depends on what the initial findings suggest and what information would be useful for planning management.
Skin biopsy
Fine-needle aspiration cytology
Lymph node assessment
Imaging and blood tests
Options & trade-offs
Management of cutaneous lymphoma is usually tailored to the extent and behaviour of the disease, the animal's overall condition, and what the owner finds workable over time. Treatment may focus on controlling skin lesions, slowing progression, or addressing discomfort and secondary infection. Different combinations of approaches suit different situations, and the balance of intensity, cost, and time commitment varies widely.
Chemotherapy
Oral or injectable chemotherapy drugs are used to target dividing lymphocytes throughout the body. Protocols vary in duration and intensity, with some given over several months and others maintained long-term. Response can range from partial reduction in lesion size or number to complete resolution of visible skin changes, though duration of response is variable.
Trade-offs: Chemotherapy requires repeated veterinary visits, monitoring blood counts, and managing potential side effects such as gastrointestinal upset or lowered immunity. It tends to be more suitable for animals with widespread or progressive disease, and costs accumulate over time.
Topical or localised therapy
Treatments applied directly to the skin, such as corticosteroid creams, retinoid gels, or localised radiation, can reduce individual lesions or patches without systemic drug exposure. These are sometimes combined with other approaches or used when disease is limited to one or a few sites.
Trade-offs: Localised therapy is less invasive and may suit animals with limited skin involvement, but it does not address lesions elsewhere or prevent new areas from developing. Response can be slow, and some animals tolerate application poorly.
Corticosteroids
Oral corticosteroids such as prednisolone can reduce inflammation and have some direct effect on lymphocyte populations. They may be used alone in animals where more intensive treatment is not pursued, or alongside other drugs. Response is often temporary, and the duration of benefit varies.
Trade-offs: Corticosteroids are widely available and relatively inexpensive, but long-term use can lead to increased thirst, appetite, and weight gain, as well as effects on organ function. They tend to offer palliation rather than long-term control in most cases.
Supportive and symptomatic care
Management of secondary skin infection, moisture barriers for ulcerated areas, and adjustments to diet or environment can reduce discomfort and improve quality of life without targeting the lymphoma directly. This may be the primary focus in animals where active treatment is declined or not tolerated.
Trade-offs: Supportive care does not slow the progression of the underlying disease, but it can address practical day-to-day concerns. It tends to suit animals with limited life expectancy from other causes, or where the burden of treatment outweighs potential benefit.
Retinoid therapy
Oral retinoids, related to vitamin A, can influence lymphocyte behaviour and skin cell turnover. They are sometimes used in combination with other treatments or in cases where standard chemotherapy is not pursued. Response is variable and may take weeks to become apparent.
Trade-offs: Retinoids require careful dosing and monitoring for side effects, which can include liver changes and dry mucous membranes. They are not available in all regions and tend to be reserved for specific situations where other options are limited.
Common misconceptions
"If the skin clears after antibiotics or steroids, the problem was not lymphoma."
Cutaneous lymphoma can respond temporarily to corticosteroids, and secondary infection often improves with antibiotics, which may give the impression that the underlying condition has resolved. Recurrence or incomplete response over time is what prompts further investigation. A period of apparent improvement does not rule out lymphoma.
"Cutaneous lymphoma always spreads to internal organs quickly."
Some animals live with skin-limited disease for months or years without detectable internal involvement, whilst others develop systemic spread relatively early. The course varies widely between individuals, and the skin-only phase can be prolonged. Staging at diagnosis provides a snapshot, but it does not predict the timeline reliably.
"Treatment will cure the condition permanently."
Most treatments for cutaneous lymphoma aim to control disease and extend good-quality time rather than eliminate the cancer entirely. Recurrence is common, and the duration of response to any given treatment varies. The goal is typically management rather than cure, with adjustments made as the disease changes over time.
Related conditions
Lymphoma in Cats
Lymphoma in cats can occur in many parts of the body, and cutaneous lymphoma represents the form in which the skin is the primary site affected. In some cases, lymphoma that began elsewhere may later involve the skin, or skin-based disease may progress to affect internal organs over time.
Alimentary Lymphoma in Cats
Alimentary lymphoma arises from the same type of cell—lymphocytes—but occurs in the gastrointestinal tract rather than the skin. The conditions share an underlying mechanism of lymphocyte malignancy, though the anatomical site and the pattern of signs observed differ between the two.
Multicentric Lymphoma in Dogs
Multicentric lymphoma in dogs involves lymph nodes rather than skin, but both conditions arise from uncontrolled multiplication of lymphocytes. In some cases, lymphoma may begin in one location and later involve others, so staging investigations often assess both nodal and cutaneous sites.
Cutaneous Histiocytosis
Cutaneous histiocytosis involves a different immune cell type—histiocytes—but can present with similar visible changes such as lumps, plaques, or nodules in the skin. The two conditions are sometimes considered together during investigation, as biopsy is often needed to distinguish between patterns of immune cell infiltration.
Mast Cell Tumours in Dogs
Mast cell tumours in dogs can appear as single or multiple skin lumps, and in some cases the pattern of distribution or appearance may overlap with cutaneous lymphoma. Biopsy is typically required to identify which type of immune cell has formed the growth, as the behaviour and treatment approaches differ.
Cutaneous lymphoma sits within a broader group of immune and ageing-related changes that can affect the skin and other systems over time. The Longevity & Healthspan pillar explores related conditions such as other forms of lymphoma, immune-mediated skin disease, and the interplay between inflammation and cancer. Understanding the shape of this condition and the range of approaches available can be a useful foundation for conversations over the coming months.